Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

The EESC calls for the creation of Good Simulation Practices

The European Economic and Social Affairs Committee (EESC) has specifically called for the creation of Good Simulation Practices as part...

find out more ›

Avicenna continues to grow by welcoming Altair among its members!

The Avicenna Alliance is proud to announce the newest addition to its list of members: Altair!

Altair is a global technology...

find out more ›

Avicenna provides feedback on the processing of personal health data in the EU

During the month of July, the Avicenna Alliance received the opportunity to provide its contribution to the European...

find out more ›

The European Medicines Agency has accepted the Avicenna Alliance's request to be directly involved in Agency activities

We are proud to announce that the European Medicines Agency (EMA) has accepted...

find out more ›

The Avicenna Alliance provided feedback on the Pharmaceutical Strategy for Europe

We are proud to announce that the Avicenna Alliance has submitted Members’ feedback to the European Commission’s...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up